Multiplicom, a Belgium-based biotech spin-out from the University of Antwerp has received €5.5m ($7.36m) from life science investors Gimv, PMV, Rudi Mariën, Qbic, and VIB.
GIMV, VIB and the University of Antwerp previously invested in the firm during a series A round in July 2011 which raised €2m ($2.68m).
Multiplicom, formed in 2010, said in a statement that the new funds will be used to accelerate growth. The firm specialises in the development, production, and sale of genetic tests based…